US Stock MarketDetailed Quotes

CYBN Cybin

Watchlist
  • 0.2999
  • -0.0001-0.03%
Close Jul 19 16:00 ET
  • 0.2946
  • -0.0053-1.77%
Post 19:34 ET
227.83MMarket Cap-1647P/E (TTM)

About Cybin Company

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Company Profile

SymbolCYBN
Company NameCybin
Listing DateAug 5, 2021
Founded2016
CEOMr. Douglas Drysdale
MarketAMEX
Employees50
Securities TypeOrdinary Shares
Fiscal Year Ends03-31
Address100 King Street West,Suite 5600
CityToronto
ProvinceOntario
CountryCanada
Zip CodeM5X 1C9
Phone1-908-764-8385

Company Executives

  • Name
  • Position
  • Salary
  • Douglas Drysdale
  • Chief Executive Officer
  • 834.17K
  • Alex Nivorozhkin
  • Chief Scientific Officer
  • --
  • Aaron Bartlone
  • Chief Operation Officer
  • 515.53K
  • Gabriel Fahel
  • Chief Legal Officer and Corporate Secretary
  • --
  • Paul Glavine
  • Director and Chief Growth Officer
  • 624.00K
  • George Tziras
  • Director and Chief Business Officer
  • --
  • Greg Cavers
  • Chief Financial Officer
  • 329.20K
  • Eric So
  • Director and President
  • 624.00K
  • Theresa Firestone
  • Lead Independent Director
  • 65.00K
  • Dr. Eric Hoskins
  • Independent Director
  • 50.00K
  • Mark Lawson
  • Independent Director
  • 50.00K
  • Grant Froese
  • Independent Director
  • 50.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg